(Neurokinin A (NKA) and Neurokinin B (NKB)) comprise the mammalian tachykinins family 84 (Pennefather et al., 2004) . Biological action of tachykinins is mediated through neurokinin 85 receptors (NKR): SP predominantly acts through NK1R, whereas NKA and NKB are 86 preferred ligands for NK2R and NK3R respectively (for review, see Maggi, 1995) . little is known about the cellular mechanisms of SP action in CE. Therefore, we thought it 110 timely to investigate in more detail the cellular mechanisms of SP action in CE. We focused 111 on the GABAergic neurons in the CEl, using electrophysiological techniques in acute slices in 112 vitro and immunocytochemical methods in glutamic acid decarboxylase-green fluorescence 113 protein (GAD67-GFP) knock-in mice (Tamamaki et al., 2003) Resting membrane potential (RMP) was measured immediately after obtaining whole-cell 156 configuration. Cells displaying a resting membrane potential positive to -55mV were 157 discarded. Neurons were held in current clamp mode at -60 mV, and the following 158 electrophysiological parameters were determined: membrane input resistance (IR), sag ratio 159 and medium afterhyperpolarization (mAHP). IR was calculated at steady state from a 160 hyperpolarizing pulse (at -30pA for 500ms) according to Ohm´s law. Sag ratio was calculated 161 as the difference between the steady-state membrane potential of a 1 s hyperpolarizing step (-162 140 pA) and the most negative membrane potential at the beginning of the step, divided by 163 the most negative value of the membrane potential. The mAHP was calculated from the 164 membrane hyperpolarization (baseline at -60 mV to the most negative potential), at 300 ms 165 after termination of a depolarizing current step (250 pA, 1 s duration, at -60 mV) evoking 166 spike firing (Schiess et all, 1993) . 167
Effects of SP were determined under current and voltage clamp conditions. For each current 168 clamp experiment, the amplitude of the voltage deflection (V) evoked by the application of 169 negative current injections (I) (-10 pA, 500 ms) at resting potential was measured, and the 170 input resistance was calculated based on Ohm´s law (R=V/I). To determine excitability action 171 potentials were evoked by positive current injections with varying amplitudes and 500 ms 172 duration. The amplitude of the depolarizing step was adjusted (range 50 -300 pA) to evoke a 173 minimum of 2 action potentials in an individual cell. neurons recorded (n=87) fell into these three categories (Fig. 1) , and only a minority of GFP-253 positive neurons (n=13) could not be classified. Examples are illustrated in Fig 1, and  254 statistical data are presented in Table 1 (Fig. 2Ab) . Upon wash-out of SP, the membrane potential 279 typically returned to resting value, and the number of spikes and input resistance amounted to 280 3.1 ± 0.6 and 436.9 ± 85.1 MΩ, respectively, not significantly differing from pre-application 281 levels (p=0.14 and p=0.48, Wilcoxon-Test). inward current at around -70 mV that displayed moderate inward rectification and a reversal 287 potential at -101.5 ± 2.8 mV (n=10 out of 18 cells) (Fig. 2Ba, Bd) . The reversal potential of 288 the SP-evoked current was near the presumed K + equilibrium potential of E K = -108.2 mV, as 289 (Fig. 2Bd) . 301
Furthermore, application of the NK1R agonist [Sar 9 ,Met(O 2 ) 11 ]-SP (300 nM) evoked an 302 inward current at around -70 mV displaying inward rectification and a reversal potential at -303 101.5 ± 2.3 mV (n=6 out of 11 tested cells in 8 mice), thereby resembling the SP-specific 304 current (Fig. 2Bc, Bd) . Overall these data indicate that NK1R are involved in mediating the 305 suppression of an inwardly rectifying potassium current in CEl neurons. were performed using NK1R-specific and PKCδ-specific antibodies in C57BL/6J mice (n=7). 312
PKCδ immunopositive reactions indicated the boundaries of the CEl. Staining for NK1Rs was 313 observed in the plasma membrane and cytoplasm of cell bodies by confocal microscopy. 314
Although the reaction product appeared somewhat punctate, it clearly rimmed the nucleus 315 forming a round to oval shaped ring and, thus, the cell was considered being NK1R-positive 316 (Fig. 3) . NK1R was expressed predominantly in PKCδ-negative cells (Fig. 3) . Only 17.5% 317 (n=42/240 cells) of NK1R-positive neurons were PKCδ-positive, whereas 80.4% (n=172/214) 318 of PKCδ-stained neurons did not display NK1R labelling. In a next series of experiments, 319 NK1R-specific antibodies were used in GAD67-GFP mice (n=2). Results revealed that NK1R 320 are expressed somatically and in the neuropile predominantly in GFP-positive cells (Fig. 4) . 321
In fact, 95.7% (n=88/92 cells) of NK1R-positive neurons were GFP-positive, while only 4.3% 322 (n=4/92) of NK1R-stained neurons did not display GFP labelling (Fig. 4) . antagonists (Fig. 5A) . Application of SP (300 nM) resulted in a significant increase in 335 frequency (from 8.06 ± 1.30 Hz to 14.43 ± 2.54 Hz; paired t-test p=0.0068) and amplitude 336 (from -56.81 ± 7.19 pA to -79.35 ± 10.27 pA; paired t-test: p=0.0498) of sIPSCs (n=13 in 12 337 mice; Fig. 5Aa, B) . Application of the NK1R agonist [Sar 9 ,Met(O 2 ) 11 ]-SP (300 nM) resulted 338 in a similar increase in frequency (from 7.89 ± 1.22 Hz to 10.87 ± 1.63 Hz; paired t-test 339 p=0.0263) and amplitude (from -71.87 ± 6.08 pA to -85.55 ± 6.62 pA; paired t-test: 340 p=0.0341) of sIPSCs (n=9 in 6 mice; Fig. 5Ab, B) . Values are means ± SE. Statistical differences between the four types of GFP-positive neurons with different firing pattern, estimated based on post hoc Bonferroni test, are marked under the corresponding parameter, P <0.05. (n) is the number of cells in a group, incidence (%) is occurrence of this type of the neuron among the recorded CEl neuronal population.
